1. Home
  2. ROP vs RVMD Comparison

ROP vs RVMD Comparison

Compare ROP & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roper Technologies Inc.

ROP

Roper Technologies Inc.

N/A

Current Price

$480.23

Market Cap

47.5B

Sector

Industrials

ML Signal

N/A

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

N/A

Current Price

$172.90

Market Cap

40.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ROP
RVMD
Founded
1981
2014
Country
United States
United States
Employees
19400
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.5B
40.3B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
ROP
RVMD
Price
$480.23
$172.90
Analyst Decision
Buy
Strong Buy
Analyst Count
19
24
Target Price
★ $469.18
$274.84
AVG Volume (30 Days)
1.1M
★ 2.2M
Earning Date
10-22-2026
11-04-2026
Dividend Yield
★ 0.84%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 21.30
N/A
Revenue
★ $7,902,500,000.00
N/A
Revenue This Year
$8.40
N/A
Revenue Next Year
$6.29
$223.88
P/E Ratio
$22.44
★ N/A
Revenue Growth
★ 12.26
N/A
52 Week Low
$305.96
$67.27
52 Week High
$507.24
$224.31

Technical Indicators

Market Signals
Indicator
ROP
RVMD
Relative Strength Index (RSI) 71.82 39.75
Support Level $343.75 $137.82
Resistance Level $507.24 $197.29
Average True Range (ATR) 12.45 9.84
MACD -0.12 -1.24
Stochastic Oscillator 65.54 9.49

Price Performance

Historical Comparison
ROP
RVMD

About ROP Roper Technologies Inc.

Roper Technologies is a holding company that reinvests cash flows from its portfolio companies into further acquisitions. The firm's operations are decentralized, while the capital allocation decisions are made at the top corporate level. As of early 2026, Roper has amassed a portfolio of nearly 30 businesses, with over three-fourths of the revenue attributable to software solutions. The firm shops for acquisitions from owner-operators, corporate carve-outs, and private equity firms, with private equity firms as the most common source for its large "platform" acquisitions.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: